Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance
AbstractActive surveillance (AS) is an important management option for men with lowrisk, clinically localized prostate cancer. The clinical parameters for patient selection and definition of progression for AS protocols are evolving as data from several large cohorts become mature. Vital to this process is the critical role pathologic parameters play in identifying appropriate candidates for AS. These findings need to be reproducible and accurately reported by pathologists. Repeated biopsy after initial diagnosis of prostate cancer is recommended before inclusion in active surveillance for early detection of significant cancer.
PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.
- Abstract views: 1116
- PDF: 445
Copyright (c) 2014 Roberta Mazzucchelli, Andrea Benedetto Galosi, Antonio Lopez-Beltran, Marina Scarpelli, Liang Cheng, Rodolfo Montironi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.